Euglycemic diabetic ketoacidosis in a patient with type 1 diabetes and SARS-CoV-2 pneumonia: case-report and review of the literature.
Acta Clin Belg
; 77(1): 113-117, 2022 Feb.
Article
in English
| MEDLINE | ID: covidwho-1900964
ABSTRACT
OBJECTIVE:
Recent publications on Coronavirus Disease-2019 (COVID-19) report that diabetic people with or without co-morbidities are at higher risk of developing severe and/or fatal illnesses. METHOD ANDRESULT:
We report the first case of a 60-year-old man with a 27-year history of type 1 diabetes mellitus, infected by SARS-CoV-2 presenting with an euglycaemic ketoacidosis and an acute respiratory distress syndrome.CONCLUSION:
This case report reminds us of the importance of adjusting more recent glucose-lowering drugs, including sodium-glucose cotransporter 2 inhibitors, in the overall management of type 1 diabetic individuals during the ongoing COVID-19 outbreak. ABBREVIATIONS COVID-19 Coronavirus disease 2019 (SARS-CoV-2) virus, T1DM Type 1 diabetes mellitus, T2DM Type 2 diabetes mellitus, SGLT2i Sodium-glucose cotransporter 2 inhibitor, DKA diabetic ketoacidosis, euDKA euglycaemic diabetic ketoacidosis.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Diabetic Ketoacidosis
/
Diabetes Mellitus, Type 1
/
Diabetes Mellitus, Type 2
/
Sodium-Glucose Transporter 2 Inhibitors
/
COVID-19
Type of study:
Case report
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Acta Clin Belg
Year:
2022
Document Type:
Article
Affiliation country:
17843286.2020.1780390
Similar
MEDLINE
...
LILACS
LIS